Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization
2001
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene
2004 StandoutNobel
Dental status, dental rehabilitation procedures, demographic and oncological data as potential risk factors for infected osteoradionecrosis of the lower jaw after radiotherapy for oral neoplasms: a retrospective evaluation
2013
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Adjuvant treatment of brain metastases
2001
Prognostic Factors in Non-small Cell Lung Cancer
2002
Molecular imaging in drug development
2008 Standout
Mutual-information-based registration of medical images: a survey
2003 Standout
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
2002 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)
2002
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Radiation for bone metastases
1997
Hydrogen peroxide mediates amyloid β protein toxicity
1994 Standout
Black Pepper and its Pungent Principle-Piperine: A Review of Diverse Physiological Effects
2007 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Palliative radiotherapy regimens for non-small cell lung cancer
2001
Head and neck cancer
2008 Standout
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)
2002
Drug-Induced Hepatotoxicity
2003 Standout
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
General Principles of External Beam Radiation Therapy for Skeletal Metastases
2003
The oxidative inactivation of cytochrome P450 in monooxygenase reactions
1994
Current Strategies in Whole-brain Radiation Therapy for Brain Metastases
2005
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
2016
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 Standout
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Conformity index: A review
2006 Standout
Leukoencephalopathy after whole‐brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer
2012
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Tolerance of normal tissue to therapeutic irradiation
1991 Standout
Brain metastases: current management and new developments
2008
Clinical molecular imaging with positron emission tomography
2006
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Three dimensional variability in patient positioning using bite block immobilization in 3D-conformal radiation treatment for ENT-tumors
1997
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Enzymic mechanisms of superoxide production
1991
Mechanisms of halothane toxicity: Novel insights
1993
Radiothérapie du cancer bronchique non à petites cellules de stade III, inopérable, asymptomatique. Résultats définitifs d'un essai prospectif randomisé (240 patients)
1999
The impact of three-dimensional radiation on the treatment of non-small cell lung cancer
2000
Palliation of Metastatic Bone Pain: Single Fraction versus Multifraction Radiotherapy – A Systematic Review of Randomised Trials
2003
Factors associated with false-positive staging of lung cancer by positron emission tomography
2000
CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
2001
Defining target volumes for non-small cell lung carcinoma
2004
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Three-dimensional motion analysis of an improved head immobilization system for simulation, CT, MRI, and PET imaging
1991
Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
2006
Prognostic factors for survival in melanoma patients with brain metastases
2010
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Artificial intelligence in radiology
2018 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases
2007
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors
2001
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
2009
Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -
2001
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Development and Validation of a Prognostic Model Using Blood Biomarker Information for Prediction of Survival of Non–Small-Cell Lung Cancer Patients Treated With Combined Chemotherapy and Radiation or Radiotherapy Alone (NCT00181519, NCT00573040, and NCT00572325)
2010
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
[27] Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy
1978
Cortisol in teleosts: dynamics, mechanisms of action, and metabolic regulation
1999 Standout
Computer-Aided Diagnosis Systems for Lung Cancer: Challenges and Methodologies
2013
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases
2003
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal Therapy Consortium
2001
The mechanism of halothane binding to microsomal cytochrome P450
1974
Computed axial tomography (CAT) contribution for dosimetry and treatment evaluation in lung cancer
1980
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial
2003
Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life
2005
Radiation for bone metastases
1997
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
PET-based treatment planning in radiotherapy: a new standard?
2007
Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes
2016 StandoutNobel
Adjuvant Therapy Of Soft-Tissue Sarcomas
1995
Pentalenolactone Biosynthesis. Molecular Cloning and Assignment of Biochemical Function to PtlI, a Cytochrome P450 of Streptomyces avermitilis
2006 StandoutNobel
Inhibition of oxidative drug metabolism in microsomes
1980
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Safrole: Its metabolism, carcinogenicity and interactions with cytochrome P-450
1981
Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy
2002
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Heme-Containing Oxygenases
1996 Standout
Mechanism of the microsomal reduction of carbon tetrachloride and halothane
1981
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade
2017 StandoutNobel
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cytochrome P450 and biological hydroxylation reactions
2005
Prognostic Factors for Survival in Adult Patients With Recurrent Glioma Enrolled Onto the New Approaches to Brain Tumor Therapy CNS Consortium Phase I and II Clinical Trials
2007
Structure and Chemistry of Cytochrome P450
2005 Standout
CNS Metastases in Breast Cancer
2004
Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial
2001
Works of K. Schnabel being referenced
FORMATION AND BINDING OF CARBANIONS BY CYTOCHROME P-450 OF LIVER MICROSOMES
1973
Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases
1998
Dose/effect relationships for brain metastases
1998
Tumor-related prognostic factors for remission of brain metastases after radiotherapy
1997
Plastic material used to optimize radiotherapy of head and neck tumors and the mammary carcinoma
1988
Late Radiation Toxicity After Whole-Brain Radiotherapy
1999
Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?
2000
Accelerated radiotherapy for brain metastases
1997
Treatment of Brain Metastases from Hypernephroma
1996
A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC)
1996
Rapid course radiation therapy vs. more standard treatment: A randomized trial for bone metastases
1996
Relation between local result and total dose of radiotherapy for brain metastases
1995
18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis
1999
A palliative accelerated irradiation regimen for advanced non–small-cell lung cancer VS. conventionally fractionated 60 GY: results of a randomized equivalence study
2000
[Tumor markers as prognostic factors in non-small-cell bronchial carcinoma].
1995
Risk factors and dose–effect relationship for osteoradionecrosis after hyperfractionated and conventionally fractionated radiotherapy for oral cancer
1996
[Experience in the use of face masks for radiotherapy of head and neck tumors].
1985
[The results of the radiotherapy of brain metastases in patients at an advanced age].
1995
Neutron and neutron-boost irradiation of soft tissue sarcomas: A 4.5 year analysis of 139 patients
1983
Ganzkörper-Computertomographie in der Planung und Kontrolle der Strahlentherapie
1977
Hyperfractionated Reirradiation for Malignant Glioma
1999
Formation and ligand binding of the fluorenyl carbanion by hepatic cytochrome P450
1973